Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Stryka 969

Next Previous
Drug Profile

Stryka 969

Alternative Names: S-969; Stryka-969

Latest Information Update: 12 Aug 2025

Price :
$50 *
Note:
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator University of Nevada Reno
  • Developer Strykagen
  • Class Small molecules
  • Mechanism of Action Integrin alpha7beta1 stimulants
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity Yes
  • Available For Licensing Yes

Highest Development Phases

  • Preclinical Duchenne muscular dystrophy
  • Research Limb girdle muscular dystrophies; Muscular dystrophies

Most Recent Events

  • 12 Aug 2025 Early research is ongoing in USA for Limb-girdle-muscular-dystrophies and Muscular-dystrophies (PO) (Strykagen pipeline, August 2025)
  • 12 Aug 2025 Preclinical trial is ongoing in USA for Duchenne muscular dystrophy (PO) (Strykagen pipeline, August 2025)
  • 28 Oct 2024 No recent reports of development identified for early research in Limb-girdle-muscular-dystrophies in USA (PO)

You need to be a logged in or subscribed to view this content

Request demo (opens in a new window)
If your organization or you do not have a subscription, try one of the following: If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top